Global Neurostimulator Device Market Research Report 2021

SKU ID :QYR-17091187 | Published Date: 05-Jan-2021 | No. of pages: 116
1 Neurostimulator Device Market Overview 1.1 Product Overview and Scope of Neurostimulator Device 1.2 Neurostimulator Device Segment by Type 1.2.1 Global Neurostimulator Device Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Stationary Neurostimulator 1.2.3 Portable Neurostimulator 1.3 Neurostimulator Device Segment by Application 1.3.1 Neurostimulator Device Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Scientific Research 1.3.4 Other 1.4 Global Neurostimulator Device Market Size Estimates and Forecasts 1.4.1 Global Neurostimulator Device Revenue 2016-2027 1.4.2 Global Neurostimulator Device Sales 2016-2027 1.4.3 Neurostimulator Device Market Size by Region: 2016 Versus 2021 Versus 2027 2 Neurostimulator Device Market Competition by Manufacturers 2.1 Global Neurostimulator Device Sales Market Share by Manufacturers (2016-2021) 2.2 Global Neurostimulator Device Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Neurostimulator Device Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Neurostimulator Device Manufacturing Sites, Area Served, Product Type 2.5 Neurostimulator Device Market Competitive Situation and Trends 2.5.1 Neurostimulator Device Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Neurostimulator Device Players Market Share by Revenue 2.5.3 Global Neurostimulator Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Neurostimulator Device Retrospective Market Scenario by Region 3.1 Global Neurostimulator Device Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Neurostimulator Device Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Neurostimulator Device Market Facts & Figures by Country 3.3.1 North America Neurostimulator Device Sales by Country 3.3.2 North America Neurostimulator Device Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Neurostimulator Device Market Facts & Figures by Country 3.4.1 Europe Neurostimulator Device Sales by Country 3.4.2 Europe Neurostimulator Device Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Neurostimulator Device Market Facts & Figures by Region 3.5.1 Asia Pacific Neurostimulator Device Sales by Region 3.5.2 Asia Pacific Neurostimulator Device Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Neurostimulator Device Market Facts & Figures by Country 3.6.1 Latin America Neurostimulator Device Sales by Country 3.6.2 Latin America Neurostimulator Device Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Neurostimulator Device Market Facts & Figures by Country 3.7.1 Middle East and Africa Neurostimulator Device Sales by Country 3.7.2 Middle East and Africa Neurostimulator Device Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Neurostimulator Device Historic Market Analysis by Type 4.1 Global Neurostimulator Device Sales Market Share by Type (2016-2021) 4.2 Global Neurostimulator Device Revenue Market Share by Type (2016-2021) 4.3 Global Neurostimulator Device Price by Type (2016-2021) 5 Global Neurostimulator Device Historic Market Analysis by Application 5.1 Global Neurostimulator Device Sales Market Share by Application (2016-2021) 5.2 Global Neurostimulator Device Revenue Market Share by Application (2016-2021) 5.3 Global Neurostimulator Device Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Cyberonics 6.1.1 Cyberonics Corporation Information 6.1.2 Cyberonics Description and Business Overview 6.1.3 Cyberonics Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Cyberonics Product Portfolio 6.1.5 Cyberonics Recent Developments/Updates 6.2 Abiomed 6.2.1 Abiomed Corporation Information 6.2.2 Abiomed Description and Business Overview 6.2.3 Abiomed Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Abiomed Product Portfolio 6.2.5 Abiomed Recent Developments/Updates 6.3 MED-EL 6.3.1 MED-EL Corporation Information 6.3.2 MED-EL Description and Business Overview 6.3.3 MED-EL Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.3.4 MED-EL Product Portfolio 6.3.5 MED-EL Recent Developments/Updates 6.4 Philips Healthcare 6.4.1 Philips Healthcare Corporation Information 6.4.2 Philips Healthcare Description and Business Overview 6.4.3 Philips Healthcare Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Philips Healthcare Product Portfolio 6.4.5 Philips Healthcare Recent Developments/Updates 6.5 Cardiac Science 6.5.1 Cardiac Science Corporation Information 6.5.2 Cardiac Science Description and Business Overview 6.5.3 Cardiac Science Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Cardiac Science Product Portfolio 6.5.5 Cardiac Science Recent Developments/Updates 6.6 Zoll Medical 6.6.1 Zoll Medical Corporation Information 6.6.2 Zoll Medical Description and Business Overview 6.6.3 Zoll Medical Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Zoll Medical Product Portfolio 6.6.5 Zoll Medical Recent Developments/Updates 6.7 Schiller 6.6.1 Schiller Corporation Information 6.6.2 Schiller Description and Business Overview 6.6.3 Schiller Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Schiller Product Portfolio 6.7.5 Schiller Recent Developments/Updates 6.8 Nihon Kohden 6.8.1 Nihon Kohden Corporation Information 6.8.2 Nihon Kohden Description and Business Overview 6.8.3 Nihon Kohden Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Nihon Kohden Product Portfolio 6.8.5 Nihon Kohden Recent Developments/Updates 6.9 GE Healthcare 6.9.1 GE Healthcare Corporation Information 6.9.2 GE Healthcare Description and Business Overview 6.9.3 GE Healthcare Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.9.4 GE Healthcare Product Portfolio 6.9.5 GE Healthcare Recent Developments/Updates 6.10 Cochlear 6.10.1 Cochlear Corporation Information 6.10.2 Cochlear Description and Business Overview 6.10.3 Cochlear Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Cochlear Product Portfolio 6.10.5 Cochlear Recent Developments/Updates 6.11 Boston Scientific 6.11.1 Boston Scientific Corporation Information 6.11.2 Boston Scientific Neurostimulator Device Description and Business Overview 6.11.3 Boston Scientific Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Boston Scientific Product Portfolio 6.11.5 Boston Scientific Recent Developments/Updates 6.12 Biotronik 6.12.1 Biotronik Corporation Information 6.12.2 Biotronik Neurostimulator Device Description and Business Overview 6.12.3 Biotronik Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Biotronik Product Portfolio 6.12.5 Biotronik Recent Developments/Updates 6.13 Sorin Group 6.13.1 Sorin Group Corporation Information 6.13.2 Sorin Group Neurostimulator Device Description and Business Overview 6.13.3 Sorin Group Neurostimulator Device Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Sorin Group Product Portfolio 6.13.5 Sorin Group Recent Developments/Updates 7 Neurostimulator Device Manufacturing Cost Analysis 7.1 Neurostimulator Device Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Neurostimulator Device 7.4 Neurostimulator Device Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Neurostimulator Device Distributors List 8.3 Neurostimulator Device Customers 9 Neurostimulator Device Market Dynamics 9.1 Neurostimulator Device Industry Trends 9.2 Neurostimulator Device Growth Drivers 9.3 Neurostimulator Device Market Challenges 9.4 Neurostimulator Device Market Restraints 10 Global Market Forecast 10.1 Neurostimulator Device Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Neurostimulator Device by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Neurostimulator Device by Type (2022-2027) 10.2 Neurostimulator Device Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Neurostimulator Device by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Neurostimulator Device by Application (2022-2027) 10.3 Neurostimulator Device Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Neurostimulator Device by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Neurostimulator Device by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer
List of Tables Table 1. Global Neurostimulator Device Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Neurostimulator Device Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Neurostimulator Device Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Neurostimulator Device Covered in This Study Table 5. Global Neurostimulator Device Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Neurostimulator Device Sales Share by Manufacturers (2016-2021) Table 7. Global Neurostimulator Device Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Neurostimulator Device Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Neurostimulator Device Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Neurostimulator Device Manufacturing Sites and Area Served Table 11. Manufacturers Neurostimulator Device Product Type Table 12. Global Neurostimulator Device Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Neurostimulator Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurostimulator Device as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Neurostimulator Device Sales by Region (2016-2021) & (K Units) Table 16. Global Neurostimulator Device Sales Market Share by Region (2016-2021) Table 17. Global Neurostimulator Device Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Neurostimulator Device Sales by Country (2016-2021) & (K Units) Table 19. North America Neurostimulator Device Sales Market Share by Country (2016-2021) Table 20. North America Neurostimulator Device Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Neurostimulator Device Revenue Market Share by Country (2016-2021) Table 22. Europe Neurostimulator Device Sales by Country (2016-2021) & (K Units) Table 23. Europe Neurostimulator Device Sales Market Share by Country (2016-2021) Table 24. Europe Neurostimulator Device Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Neurostimulator Device Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Neurostimulator Device Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Neurostimulator Device Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Neurostimulator Device Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Neurostimulator Device Revenue Market Share by Region (2016-2021) Table 30. Latin America Neurostimulator Device Sales by Country (2016-2021) & (K Units) Table 31. Latin America Neurostimulator Device Sales Market Share by Country (2016-2021) Table 32. Latin America Neurostimulator Device Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Neurostimulator Device Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Neurostimulator Device Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Neurostimulator Device Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Neurostimulator Device Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Neurostimulator Device Revenue Market Share by Country (2016-2021) Table 38. Global Neurostimulator Device Sales (K Units) by Type (2016-2021) Table 39. Global Neurostimulator Device Sales Market Share by Type (2016-2021) Table 40. Global Neurostimulator Device Revenue (Million US$) by Type (2016-2021) Table 41. Global Neurostimulator Device Revenue Share by Type (2016-2021) Table 42. Global Neurostimulator Device Price (USD/Unit) by Type (2016-2021) Table 43. Global Neurostimulator Device Sales (K Units) by Application (2016-2021) Table 44. Global Neurostimulator Device Sales Market Share by Application (2016-2021) Table 45. Global Neurostimulator Device Revenue (Million US$) by Application (2016-2021) Table 46. Global Neurostimulator Device Revenue Share by Application (2016-2021) Table 47. Global Neurostimulator Device Price (USD/Unit) by Application (2016-2021) Table 48. Cyberonics Corporation Information Table 49. Cyberonics Description and Business Overview Table 50. Cyberonics Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Cyberonics Neurostimulator Device Product Table 52. Cyberonics Recent Developments/Updates Table 53. Abiomed Corporation Information Table 54. Abiomed Description and Business Overview Table 55. Abiomed Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Abiomed Neurostimulator Device Product Table 57. Abiomed Recent Developments/Updates Table 58. MED-EL Corporation Information Table 59. MED-EL Description and Business Overview Table 60. MED-EL Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. MED-EL Neurostimulator Device Product Table 62. MED-EL Recent Developments/Updates Table 63. Philips Healthcare Corporation Information Table 64. Philips Healthcare Description and Business Overview Table 65. Philips Healthcare Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Philips Healthcare Neurostimulator Device Product Table 67. Philips Healthcare Recent Developments/Updates Table 68. Cardiac Science Corporation Information Table 69. Cardiac Science Description and Business Overview Table 70. Cardiac Science Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Cardiac Science Neurostimulator Device Product Table 72. Cardiac Science Recent Developments/Updates Table 73. Zoll Medical Corporation Information Table 74. Zoll Medical Description and Business Overview Table 75. Zoll Medical Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Zoll Medical Neurostimulator Device Product Table 77. Zoll Medical Recent Developments/Updates Table 78. Schiller Corporation Information Table 79. Schiller Description and Business Overview Table 80. Schiller Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Schiller Neurostimulator Device Product Table 82. Schiller Recent Developments/Updates Table 83. Nihon Kohden Corporation Information Table 84. Nihon Kohden Description and Business Overview Table 85. Nihon Kohden Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Nihon Kohden Neurostimulator Device Product Table 87. Nihon Kohden Recent Developments/Updates Table 88. GE Healthcare Corporation Information Table 89. GE Healthcare Description and Business Overview Table 90. GE Healthcare Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. GE Healthcare Neurostimulator Device Product Table 92. GE Healthcare Recent Developments/Updates Table 93. Cochlear Corporation Information Table 94. Cochlear Description and Business Overview Table 95. Cochlear Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Cochlear Neurostimulator Device Product Table 97. Cochlear Recent Developments/Updates Table 98. Boston Scientific Corporation Information Table 99. Boston Scientific Description and Business Overview Table 100. Boston Scientific Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Boston Scientific Neurostimulator Device Product Table 102. Boston Scientific Recent Developments/Updates Table 103. Biotronik Corporation Information Table 104. Biotronik Description and Business Overview Table 105. Biotronik Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. Biotronik Neurostimulator Device Product Table 107. Biotronik Recent Developments/Updates Table 108. Sorin Group Corporation Information Table 109. Sorin Group Description and Business Overview Table 110. Sorin Group Neurostimulator Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Sorin Group Neurostimulator Device Product Table 112. Sorin Group Recent Developments/Updates Table 113. Production Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Neurostimulator Device Distributors List Table 116. Neurostimulator Device Customers List Table 117. Neurostimulator Device Market Trends Table 118. Neurostimulator Device Growth Drivers Table 119. Neurostimulator Device Market Restraints Table 120. Global Neurostimulator Device Sales Forecast by Type (2022-2027) & (K Units) Table 121. Global Neurostimulator Device Sales Market Share Forecast by Type (2022-2027) Table 122. Global Neurostimulator Device Revenue Forecast by Type (2022-2027) & (US$ Million) Table 123. Global Neurostimulator Device Revenue Market Share Forecast by Type (2022-2027) Table 124. Global Neurostimulator Device Sales Forecast by Application (2022-2027) & (K Units) Table 125. Global Neurostimulator Device Sales Market Share Forecast by Application (2022-2027) Table 126. Global Neurostimulator Device Revenue Forecast by Application (2022-2027) & (US$ Million) Table 127. Global Neurostimulator Device Revenue Market Share Forecast by Application (2022-2027) Table 128. Global Neurostimulator Device Sales Forecast by Region (2022-2027) & (K Units) Table 129. Global Neurostimulator Device Sales Market Share Forecast by Region (2022-2027) Table 130. Global Neurostimulator Device Revenue Forecast by Region (2022-2027) & (US$ Million) Table 131. Global Neurostimulator Device Revenue Market Share Forecast by Region (2022-2027) Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Neurostimulator Device Figure 2. Global Neurostimulator Device Market Share by Type in 2020 & 2027 Figure 3. Stationary Neurostimulator Product Picture Figure 4. Portable Neurostimulator Product Picture Figure 5. Global Neurostimulator Device Market Share by Application in 2020 & 2027 Figure 6. Hospital Figure 7. Scientific Research Figure 8. Other Figure 9. Global Neurostimulator Device Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Neurostimulator Device Market Size 2016-2027 (US$ Million) Figure 11. Global Neurostimulator Device Sales 2016-2027 (K Units) Figure 12. Global Neurostimulator Device Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Neurostimulator Device Sales Share by Manufacturers in 2020 Figure 14. Global Neurostimulator Device Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Neurostimulator Device Players: Market Share by Revenue in 2020 Figure 16. Neurostimulator Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Neurostimulator Device Sales Market Share by Region (2016-2021) Figure 18. Global Neurostimulator Device Sales Market Share by Region in 2020 Figure 19. Global Neurostimulator Device Revenue Market Share by Region (2016-2021) Figure 20. Global Neurostimulator Device Revenue Market Share by Region in 2020 Figure 21. U.S. Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE Neurostimulator Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Neurostimulator Device by Type (2016-2021) Figure 46. Sales Market Share of Neurostimulator Device by Application (2016-2021) Figure 47. Sales Market Share of Neurostimulator Device by Application in 2020 Figure 48. Revenue Share of Neurostimulator Device by Application (2016-2021) Figure 49. Revenue Share of Neurostimulator Device by Application in 2020 Figure 50. Manufacturing Cost Structure of Neurostimulator Device Figure 51. Manufacturing Process Analysis of Neurostimulator Device Figure 52. Neurostimulator Device Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed
Cyberonics Abiomed MED-EL Philips Healthcare Cardiac Science Zoll Medical Schiller Nihon Kohden GE Healthcare Cochlear Boston Scientific Biotronik Sorin Group
  • PRICE
  • $2900
    $5800
    $4350
    Buy Now

Our Clients